Drug Profile
MK 8876
Alternative Names: MK-8876Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Hepatitis-C in Germany (PO)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Hepatitis-C in Moldova (PO)
- 11 Oct 2013 Phase-I clinical trials in Hepatitis C in Germany (PO)